Why It Matters
Stamford Health is fighting to protect its revenue as Congress debates policies threatening hospital finances. Federal payment reforms targeting site-neutral reimbursement, facility fees, and Medicare Advantage practices could significantly reduce income.
Meanwhile, massive federal funding cuts—including a $1 trillion healthcare reduction in 2025—are squeezing margins nationwide. By hiring BGR Government Affairs LLC, Stamford Health is positioning itself to influence high-stakes debates over hospital payment restructuring.
By the Numbers
Stamford Health paid BGR Government Affairs LLC $80,000 in Q4 2025, bringing total 2025 spending to $270,000. This marks the health system’s first year of federal lobbying, which began in April 2025.
BGR assembled a four-person team with significant congressional experience. Remy Leigh Brim Mason served as Senior Adviser for Health Policy for Senator Elizabeth Warren and the Senate HELP Committee. Daniel Christopher Farmer worked six years in the House. Christopher P. Kelly and Marvin Benito Figueroa bring Republican Senate experience and bipartisan access.
Hospital industry lobbying jumped 16 percent to $653 million in the first three quarters of 2025.
The Agenda
Stamford Health is lobbying on "federal payment and policy issues and government funding impacting hospitals," targeting several high-stakes policy areas:
- Site-neutral payments: Rep. Timothy M. Kennedy’s Same Care, Lower Cost Act would expand site-neutral payments to all hospital outpatient departments, potentially reducing revenue.
- Medicare Advantage reimbursement: The bipartisan Medicare Advantage Prompt Pay Act addresses delayed payments from MA plans.
- Rural hospital funding: Proposed legislation like H.R.3684 – Save America’s Rural Hospitals Act would modify Medicare sequestration and Disproportionate Share Hospital payments.
- Billing transparency: The Fair Billing Act aims to restrict facility fees charged by hospital-owned physician offices.
Broader Context
Congress is actively reshaping hospital finances. The Trump administration’s 2026 Medicare rule extends site-neutral payments to drug administration services, reducing rates by 60 percent. President Trump signed legislation slashing nearly $1 trillion from federal health funding over a decade. Hospitals face negative 10% Medicare margins in 2026.
Additional threats include facility fee restrictions and Medicare Advantage payment delays, with 79 percent of Americans supporting billing limits.
Between The Lines
Key legislative developments directly affect Stamford Health’s revenue. An upcoming Senate HELP Committee Business Meeting will address rural hospital policy, while House committees examine post-acute care financial pressures.
The Fair Billing Act from Sens. Maggie Hassan (D-NH) and Roger Marshall (R-KS) represents bipartisan momentum against hospital facility fees—a significant revenue source.
Competitive Landscape
Hospital systems nationwide are engaging in unprecedented lobbying as Congress threatens institutional finances. Other major institutions like the University of Rochester and Medical University Hospital Authority are lobbying on identical payment mechanisms: Inpatient and Outpatient Prospective Payment Systems, DSH payments, 340B Drug Discount Program, and graduate medical education funding.
The American Hospital Association increased Q1 2025 lobbying investment to $7.03 million, reflecting industry-wide urgency.
The Bottom Line
Stamford Health’s $270,000 lobbying investment reflects the existential threat facing hospitals. With Congress advancing site-neutral payment expansions, facility fee restrictions, and Medicare reforms, the Connecticut health system is part of a record-breaking industry effort to protect traditional revenue streams while pursuing relief from Medicare Advantage delays.
Access the Legis1 platform for comprehensive political news, data, and insights.